-
公开(公告)号：US07361744B2
公开(公告)日：2008-04-22
申请号：US11193655
申请日：2005-07-28
Applicant: Takeshi Honda , Akira Okuno , Masanori Izumi , Xiaoliu Li
Inventor： Takeshi Honda , Akira Okuno , Masanori Izumi , Xiaoliu Li
CPC classification number: C07H15/203 , C07H17/02
Abstract: Compounds having the formula (I): wherein A represents a group such as a cyclic group, R1 and R2 represent groups such as alkyl groups or hydroxymethyl groups, and n represents 1 or 2, or pharmacologically acceptable salts thereof or pharmacologically acceptable esters thereof have superior activity and stability, and are useful for the treatment and/or prevention of diabetes mellitus, or the like.
Abstract translation: 具有式（I）的化合物：其中A表示诸如环状基团的基团，R 1和R 2表示例如烷基或羟甲基的基团，n 代表1或2，或其药学上可接受的盐或其药理学上可接受的酯具有优异的活性和稳定性，并且可用于治疗和/或预防糖尿病等。
-
公开(公告)号：US20060025350A1
公开(公告)日：2006-02-02
申请号：US11193655
申请日：2005-07-28
Applicant: Takeshi Honda , Akira Okuno , Masanori Izumi , Xiaoliu Li
Inventor： Takeshi Honda , Akira Okuno , Masanori Izumi , Xiaoliu Li
IPC: C07H15/02 , A61K31/7052
CPC classification number: C07H15/203 , C07H17/02
Abstract: Compounds having the formula (I): wherein A represents a group such as a cyclic group, R1 and R2 represent groups such as alkyl groups or hydroxymethyl groups, and n represents 1 or 2, or pharmacologically acceptable salts thereof or pharmacologically acceptable esters thereof have superior activity and stability, and are useful for the treatment and/or prevention of diabetes mellitus, or the like.
Abstract translation: 具有式（I）的化合物：其中A表示诸如环状基团的基团，R 1和R 2表示例如烷基或羟甲基的基团，n 代表1或2，或其药学上可接受的盐或其药理学上可接受的酯具有优异的活性和稳定性，并且可用于治疗和/或预防糖尿病等。
-
公开(公告)号：US07632930B2
公开(公告)日：2009-12-15
申请号：US12029337
申请日：2008-02-11
Applicant: Takeshi Honda , Akira Okuno , Masanori Izumi , Xiaoliu Li
Inventor： Takeshi Honda , Akira Okuno , Masanori Izumi , Xiaoliu Li
CPC classification number: C07H15/203 , C07H17/02
Abstract: Compounds having the formula (I): wherein A represents a group such as a cyclic group, R1 and R2 represent groups such as alkyl groups or hydroxymethyl groups, and n represents 1 or 2, or pharmacologically acceptable salts thereof or pharmacologically acceptable esters thereof have superior activity and stability, and are useful for the treatment and/or prevention of diabetes mellitus, or the like.
Abstract translation: 具有式（I）的化合物：其中A表示诸如环状基团的基团，R 1和R 2表示诸如烷基或羟甲基的基团，n表示1或2，或其药学上可接受的盐或其药理学上可接受的酯具有 优异的活性和稳定性，并且可用于治疗和/或预防糖尿病等。
-
公开(公告)号：US20080194495A1
公开(公告)日：2008-08-14
申请号：US12029337
申请日：2008-02-11
Applicant: Takeshi Honda , Akira Okuno , Masanori Izumi , Xiaoliu Li
Inventor： Takeshi Honda , Akira Okuno , Masanori Izumi , Xiaoliu Li
IPC: A61K31/702 , C07H15/02 , A61P3/10
CPC classification number: C07H15/203 , C07H17/02
Abstract: Compounds having the formula (I): wherein A represents a group such as a cyclic group, R1 and R2 represent groups such as alkyl groups or hydroxymethyl groups, and n represents 1 or 2, or pharmacologically acceptable salts thereof or pharmacologically acceptable esters thereof have superior activity and stability, and are useful for the treatment and/or prevention of diabetes mellitus, or the like.
Abstract translation: 具有式（I）的化合物：其中A表示诸如环状基团的基团，R 1和R 2表示例如烷基或羟甲基的基团，n 代表1或2，或其药学上可接受的盐或其药理学上可接受的酯具有优异的活性和稳定性，并且可用于治疗和/或预防糖尿病等。
-
-
-
Search Results
4
records
(took 0.015 seconds)
